一例转移性直乙交界癌患者治疗的反思
摘要
一、病例简介 患者女性,30岁,2012年5月因“便秘伴大便少量带血4月余”入我院。患者既往体健;否认高血压、糖尿病、心脏病等慢性病史;否认肝炎、结核等传染病史;否认家族性遗传病史。患者已婚,育有1子。查体:体力状况评分( Zubrod-ECOG-WHO,5分法)0分;全身各浅表淋巴结未及肿大;心肺检查无异常;腹软,全腹无压痛、反跳痛,未触及肿块;肝脾肋下未触及;无移动性浊音;直肠指检未及明显异常。
出处
《中华结直肠疾病电子杂志》
2014年第1期46-48,共3页
Chinese Journal of Colorectal Diseases(Electronic Edition)
参考文献12
-
1Schmoll HJ,Van Cutsem E,Stein A. ESMO Consensus Guidelines for management of patients with colon and rectal cancer.a personalized approach to clinical decision making[J].ANNALS OF ONCOLOGY,2012,(10):2479-2516.
-
2Adam R,Aloia T,Levi F. Hepatic resection after rescue cetuximab treatment for colorectal liver metastases previously refractory to conventional systemic therapy[J].Journal of Clinical Oncology,2007,(29):4593-4602.
-
3Souglakos J,Androulakis N,Syrigos K. FOLFOXIRI(folinic acid,5-fluorouracil,oxaliplatin and irinotecan) vs FOLFIRI (folinic acid,5-fluorouracil and irinotecan)as flrst-line treatment in metastatic colorectal cancer(MCC):a multicentre randomised phase III trial from the Hellenic Oncology Research Group (HORG)[J].British Journal of Cancer,2006,(06):798-805.
-
4Saltz LB,Clarke S,Diaz-Rubio E. Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer:a randomized phase III study[J].Journal of Clinical Oncology,2008,(12):2013-2019.
-
5Macedo LT,da Costa Lima AB,Sasse AD. Addition of bevacizumab to first-line chemotherapy in advanced colorectal cancer:a systematic review and meta-analysis,with emphasis on chemotherapy subgroups[J].BMC Cancer,2012,(89).
-
6Gerlinger M1,Rowan AJ,Horswell S. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing[J].New England Journal of Medicine,2012,(10):883-892.
-
7Kreso A1,O'Brien CA,van Galen P. Variable clonal repopulation dynamics influence chemotherapy response in colorectal cancer[J].SCIENCE,2013,(6119):543-548.
-
8Adam R,De Gramont A,Figueras J. The oncosurgery approach to managing liver metastases from colorectal cancer:a multidisciplinary international consensus[J].Oncologist(the)t,2012,(10):1225-1239.
-
9Giessen C,Laubender RP,Fischer von Weikersthal L. Early tumor shrinkage in metastatic colorectal cancer:retrospective analysis from an irinotecan-based randomized first-line trial[J].CANCER SCIENCE,2013,(06):718-724.
-
10Modest DP,Laubender RP,Stintzing S. Early tumor shrinkage in patients with metastatic colorectal cancer receiving first-line treatment with cetuximab combined with either CAPIRI or CAPOX:an analysis of the German AIO KRK 0104 trial[J].ACTA ONCOLOGICA,2013,(05):956-962.
二级参考文献20
-
1Forastiere AA, Goepfert H , Maor M,et al. Concurrent Chemotherapy and Radiotherapy for Organ Preservation in Advanced Laryngeal Cancer[J]. N Engl J Med ,2003, 349(22):2091-2098.
-
2Kopetz S, Chang G J, Overman M J, et al. Improved Survival in Metastatic Colorectal Cancer Is Associated With Adoption of Hepatic Resection and Improved Chemotherapy [J]. J Clin Oncol, 2009,27(22):3677-3683.
-
3Department of Health. Policy framework for commissioning cancer services: a report by the expert advisory group on cancer to the chief medical officers of England and Wales [M]. London: Department of Health, 1995.
-
4Richards MA, Baum M, Dowsett M. Provision of breast services in the UK: the advantages of specialist breast units [M]. British Breast Group, 199d.
-
5National Institute for Health and Clinical Excellence. Chronic obstructive pulmonary disease. Management of chronic obstructive pulmonary disease in adults in primary and secondary care [M]. NICE, 2004.
-
6Department of Health. Coronary heart disease: national service framework for coronary heart disease--modem standards and service models [ M ]. London: Department of Health, 2000.
-
7Department of Health. The manual for cancer services[M]. London: Department of Health, 2004.
-
8Wilke H. An international muhidiseiplinary approach to the management of advanced colorectal cancer. The International Working Group in Colorectal Cancer [J]. Anticancer Drugs, 1997, 8(suppl 2): 27-31.
-
9Borrill C, West M, Shapiro D, et al. Team working and effectiveness in health care [J]. Br J Health Care Manage ,2000, 6 (8): 364-371.
-
10Molyneux J. Interprofessional teamworking: what makes teamswork well?[J]. J Interpr Care, 2001,15(1): 29-35.
共引文献44
-
1邓维成,王洪波,荆群山,刘佳新,朱剑君,任光辉,李岳生.血吸虫病的临床路径探讨[J].中国血吸虫病防治杂志,2012,24(5):601-604. 被引量:3
-
2邓维成,赵正元,刘佳新,李胜明,郭凤英,王璋华,任光辉,李岳生.多学科综合治疗晚期血吸虫病效果观察[J].中国血吸虫病防治杂志,2013,25(1):67-69. 被引量:13
-
3秦新裕,冯青阳,许剑民.重视并规范化开展结直肠癌肝转移多学科综合治疗[J].中国实用外科杂志,2013,33(8):619-621. 被引量:20
-
4冯青阳,许剑民.多学科团队在结直肠癌肝转移诊断与治疗中的应用[J].中华消化外科杂志,2014,13(3):230-233. 被引量:12
-
5纪智勇,吴清龙,张开颜,李伟,吴准,邢金春.多学科专家组诊治青年分泌醛固酮肾上腺皮质腺癌1例[J].临床泌尿外科杂志,2014,29(4):368-369.
-
6钟森林,田学根,陈德银,盛荣,刘承海.临床路径在腹水型晚期血吸虫病患者中的应用效果评价[J].热带病与寄生虫学,2014,12(3):143-145. 被引量:2
-
7郭芝廷,金静芬.成批中重度烧伤患者的气道管理[J].中华护理杂志,2015,50(4):435-438. 被引量:21
-
8黄亚博,冯广清,陈宁,商璐.江苏省中医药系统多专业一体化诊疗模式实施情况调查报告——兼谈对中医药系统多专业一体化诊疗模式的思考[J].江苏中医药,2015,47(7):5-9. 被引量:4
-
9李晓宁,綦雪巍,迟蕾,臧召霞,王玉琳,刘双岭,孔菲,徐涛.开展基于针灸的脊髓损伤多学科综合治疗思考[J].针灸临床杂志,2015,31(9):83-86. 被引量:2
-
10杨军,李文亮,文政琦,王志强,刘为青.多学科协作诊疗模式在肿瘤科实习医生培养中的作用[J].卫生职业教育,2016,34(7):137-138. 被引量:3
-
1冯大作,陈勇,雷三林.从直肠癌的术后复发反思直肠癌根治术的注意事项[J].中国现代医学杂志,1998,8(12):49-49. 被引量:10
-
2刘永邻.我院癌症发病情况报告与反思[J].重庆师范学院学报(自然科学版),1993,10(4):93-96. 被引量:1
-
3冯大作,陈勇,雷三林.从直肠癌的术后复发对直肠癌根治术的反思[J].大肠肛门病外科杂志,1998,4(3):49-50.
-
4陈忠平.胶质瘤治疗的困惑与思考[J].中华神经外科杂志,2008,24(4):310-311. 被引量:13
-
5陈砚平.肝癌研究的几点反思[J].医学与哲学,1993,14(2):44-45. 被引量:1
-
6胡天贵,李丽,李志强.后颅凹肿瘤术后并发血肿21例反思[J].临床误诊误治,1999,12(2):140-140. 被引量:2
-
7胡敏.关于抑癌基因p53认识过程的反思[J].医学与哲学,1994,15(7):30-32. 被引量:2
-
8唐努尔.艾尔肯,阿西木江.肠梗阻术中发生休克一例反思[J].临床误诊误治,2008,21(2):53-53.
-
9张肇宇,张艳秋.PFNA联合中药口服治疗老年股骨转子间骨折36例[J].福建中医药,2012,43(3):44-44. 被引量:3
-
10李青.血清胱抑素C在慢性肾功能衰竭诊断中的价值[J].检验医学与临床,2015,12(16):2449-2450. 被引量:18